In the last 18 months, $Eli Lilly and Co (LLY.US)$ 's mkt ca...

In the last 18 months, $Eli Lilly and Co (LLY.US)$ 's mkt cap has moved from $340B to roughly $770B today, there has to be close to $300-$400B attributed to GLP-1, agree? If close to being true, this just simply points to dramatic undervaluation of $Viking Therapeutics (VKTX.US)$ with only a $7B mkt cap and what looks like a better GLP-1 franchise. Big pharma wastes a lot of money on stupid deals but this one at $15B is a lay-up. I think a BO happens any day and at a huge premium. Anyone smart enough to buy them probably adds that to their mkt cap on day 1 and essentially gets the company for nothing.